Literature DB >> 27682981

Identification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events.

María Laura Matos1, Lara Lapyckyj1, Marina Rosso1, María José Besso1, María Victoria Mencucci1, Clara Isabel Marín Briggiler1, Silvina Giustina1, Laura Inés Furlong1, Mónica Hebe Vazquez-Levin1.   

Abstract

Epithelial Cadherin (E-cadherin) is involved in calcium-dependent cell-cell adhesion and signal transduction. The E-cadherin decrease/loss is a hallmark of Epithelial to Mesenchymal Transition (EMT), a key event in tumor progression. The underlying molecular mechanisms that trigger E-cadherin loss and consequent EMT have not been completely elucidated. This study reports the identification of a novel human E-cadherin variant mRNA produced by alternative splicing. A bioinformatics evaluation of the novel mRNA sequence and biochemical verifications suggest its regulation by Nonsense-Mediated mRNA Decay (NMD). The novel E-cadherin variant was detected in 29/42 (69%) human tumor cell lines, expressed at variable levels (E-cadherin variant expression relative to the wild type mRNA = 0.05-11.6%). Stable transfection of the novel E-cadherin variant in MCF-7 cells (MCF7Ecadvar) resulted in downregulation of wild type E-cadherin expression (transcript/protein) and EMT-related changes, among them acquisition of a fibroblastic-like cell phenotype, increased expression of Twist, Snail, Zeb1, and Slug transcriptional repressors and decreased expression of ESRP1 and ESRP2 RNA binding proteins. Moreover, loss of cytokeratins and gain of vimentin, N-cadherin and Dysadherin/FXYD5 proteins was observed. Dramatic changes in cell behavior were found in MCF7Ecadvar, as judged by the decreased cell-cell adhesion (Hanging-drop assay), increased cell motility (Wound Healing) and increased cell migration (Transwell) and invasion (Transwell w/Matrigel). Some changes were found in MCF-7 cells incubated with culture medium supplemented with conditioned medium from HEK-293 cells transfected with the E-cadherin variant mRNA. Further characterization of the novel E-cadherin variant will help understanding the molecular basis of tumor progression and improve cancer diagnosis. J. Cell. Physiol. 232: 1368-1386, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27682981     DOI: 10.1002/jcp.25622

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  17 in total

1.  Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B.

Authors:  Marina Rosso; Lara Lapyckyj; María José Besso; Marta Monge; Jaume Reventós; Francesc Canals; Jorge Oswaldo Quevedo Cuenca; María Laura Matos; Mónica Hebe Vazquez-Levin
Journal:  Cancer Metab       Date:  2019-05-09

2.  E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.

Authors:  Marina Rosso; Blanca Majem; Laura Devis; Lara Lapyckyj; María José Besso; Marta Llauradó; María Florencia Abascal; María Laura Matos; Lucia Lanau; Josep Castellví; José Luis Sánchez; Asunción Pérez Benavente; Antonio Gil-Moreno; Jaume Reventós; Anna Santamaria Margalef; Marina Rigau; Mónica Hebe Vazquez-Levin
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

3.  Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.

Authors:  Michele Sook Yuin Hiew; Han Ping Cheng; Chiu-Jung Huang; Kowit Yu Chong; Soon Keng Cheong; Kong Bung Choo; Tunku Kamarul
Journal:  J Biomed Sci       Date:  2018-07-19       Impact factor: 8.410

Review 4.  Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.

Authors:  Hong-Tao Chen; Hao Liu; Min-Jie Mao; Yuan Tan; Xiang-Qiong Mo; Xiao-Jun Meng; Meng-Ting Cao; Chu-Yu Zhong; Yan Liu; Hong Shan; Guan-Min Jiang
Journal:  Mol Cancer       Date:  2019-05-24       Impact factor: 27.401

5.  The strong propensity of Cadherin-23 for aggregation inhibits cell migration.

Authors:  Malay K Sannigrahi; Cheerneni S Srinivas; Nilesh Deokate; Sabyasachi Rakshit
Journal:  Mol Oncol       Date:  2019-03-19       Impact factor: 6.603

6.  DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells.

Authors:  Kyoung Ah Kang; Yea Seong Ryu; Mei Jing Piao; Kristina Shilnikova; Hee Kyoung Kang; Joo Mi Yi; Mathias Boulanger; Rosa Paolillo; Guillaume Bossis; Sung Young Yoon; Seong Bong Kim; Jin Won Hyun
Journal:  Redox Biol       Date:  2018-04-23       Impact factor: 11.799

7.  Chronic stress promotes EMT-mediated metastasis through activation of STAT3 signaling pathway by miR-337-3p in breast cancer.

Authors:  Peixin Du; Hao Zeng; Yinan Xiao; Yunuo Zhao; Bo Zheng; Yaotiao Deng; Jie Liu; Boyan Huang; Xinyao Zhang; Keyi Yang; Yu Jiang; Xuelei Ma
Journal:  Cell Death Dis       Date:  2020-09-15       Impact factor: 8.469

Review 8.  The E-Cadherin Cleavage Associated to Pathogenic Bacteria Infections Can Favor Bacterial Invasion and Transmigration, Dysregulation of the Immune Response and Cancer Induction in Humans.

Authors:  Christian A Devaux; Soraya Mezouar; Jean-Louis Mege
Journal:  Front Microbiol       Date:  2019-11-08       Impact factor: 5.640

Review 9.  Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer.

Authors:  Antonietta Rosella Farina; Lucia Cappabianca; Michela Sebastiano; Veronica Zelli; Stefano Guadagni; Andrew Reay Mackay
Journal:  J Exp Clin Cancer Res       Date:  2020-06-15

10.  TRAF2 Is a Novel Ubiquitin E3 Ligase for the Na,K-ATPase β-Subunit That Drives Alveolar Epithelial Dysfunction in Hypercapnia.

Authors:  Nieves M Gabrielli; Luciana C Mazzocchi; Vitalii Kryvenko; Khodr Tello; Susanne Herold; Rory E Morty; Friedrich Grimminger; Laura A Dada; Werner Seeger; Jacob I Sznajder; István Vadász
Journal:  Front Cell Dev Biol       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.